Covis Pharma GMBH

Switzerland · Reporting entity ID 100000316823

Total reported 2019–2025

$3.33M

#849 of 2,960 reporting companies — 0% of all reported industry payments

$260K in general payments across 7,736 records, plus $3.07M in research funding across 21 records.

How it breaks down

General payments $260,263

Research funding $3,073,103

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.